nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0265	0.291	CbGbCtD
Cevimeline—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0246	0.271	CbGbCtD
Cevimeline—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0113	0.124	CbGbCtD
Cevimeline—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0111	0.122	CbGbCtD
Cevimeline—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0104	0.114	CbGbCtD
Cevimeline—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00706	0.0777	CbGbCtD
Cevimeline—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.00029	CcSEcCtD
Cevimeline—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000264	0.00029	CcSEcCtD
Cevimeline—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000262	0.000288	CcSEcCtD
Cevimeline—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000261	0.000287	CcSEcCtD
Cevimeline—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000287	CcSEcCtD
Cevimeline—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00026	0.000286	CcSEcCtD
Cevimeline—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00026	0.000285	CcSEcCtD
Cevimeline—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000257	0.000283	CcSEcCtD
Cevimeline—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000282	CcSEcCtD
Cevimeline—Pain—Cisplatin—peripheral nervous system neoplasm	0.000257	0.000282	CcSEcCtD
Cevimeline—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000282	CcSEcCtD
Cevimeline—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000282	CcSEcCtD
Cevimeline—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000279	CcSEcCtD
Cevimeline—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000253	0.000278	CcSEcCtD
Cevimeline—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000278	CcSEcCtD
Cevimeline—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000277	CcSEcCtD
Cevimeline—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000276	CcSEcCtD
Cevimeline—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000276	CcSEcCtD
Cevimeline—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.00025	0.000275	CcSEcCtD
Cevimeline—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00025	0.000275	CcSEcCtD
Cevimeline—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000249	0.000274	CcSEcCtD
Cevimeline—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000273	CcSEcCtD
Cevimeline—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000272	CcSEcCtD
Cevimeline—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000247	0.000272	CcSEcCtD
Cevimeline—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000247	0.000272	CcSEcCtD
Cevimeline—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000271	CcSEcCtD
Cevimeline—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000245	0.00027	CcSEcCtD
Cevimeline—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000245	0.00027	CcSEcCtD
Cevimeline—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000269	CcSEcCtD
Cevimeline—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000244	0.000269	CcSEcCtD
Cevimeline—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000269	CcSEcCtD
Cevimeline—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000244	0.000268	CcSEcCtD
Cevimeline—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000267	CcSEcCtD
Cevimeline—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000242	0.000266	CcSEcCtD
Cevimeline—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000265	CcSEcCtD
Cevimeline—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000241	0.000265	CcSEcCtD
Cevimeline—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00024	0.000264	CcSEcCtD
Cevimeline—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000239	0.000263	CcSEcCtD
Cevimeline—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000237	0.000261	CcSEcCtD
Cevimeline—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000237	0.000261	CcSEcCtD
Cevimeline—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000237	0.000261	CcSEcCtD
Cevimeline—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000259	CcSEcCtD
Cevimeline—Constipation—Etoposide—peripheral nervous system neoplasm	0.000235	0.000259	CcSEcCtD
Cevimeline—Pain—Etoposide—peripheral nervous system neoplasm	0.000235	0.000259	CcSEcCtD
Cevimeline—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000258	CcSEcCtD
Cevimeline—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000258	CcSEcCtD
Cevimeline—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000258	CcSEcCtD
Cevimeline—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000256	CcSEcCtD
Cevimeline—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000233	0.000256	CcSEcCtD
Cevimeline—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000232	0.000255	CcSEcCtD
Cevimeline—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000255	CcSEcCtD
Cevimeline—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000253	CcSEcCtD
Cevimeline—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000252	CcSEcCtD
Cevimeline—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000251	CcSEcCtD
Cevimeline—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000251	CcSEcCtD
Cevimeline—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.00025	CcSEcCtD
Cevimeline—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000249	CcSEcCtD
Cevimeline—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000227	0.000249	CcSEcCtD
Cevimeline—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000249	CcSEcCtD
Cevimeline—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000226	0.000248	CcSEcCtD
Cevimeline—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000248	CcSEcCtD
Cevimeline—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000247	CcSEcCtD
Cevimeline—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000225	0.000247	CcSEcCtD
Cevimeline—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000224	0.000247	CcSEcCtD
Cevimeline—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000224	0.000246	CcSEcCtD
Cevimeline—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000222	0.000244	CcSEcCtD
Cevimeline—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000222	0.000244	CcSEcCtD
Cevimeline—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000221	0.000243	CcSEcCtD
Cevimeline—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000221	0.000243	CcSEcCtD
Cevimeline—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000241	CcSEcCtD
Cevimeline—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000218	0.00024	CcSEcCtD
Cevimeline—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000218	0.00024	CcSEcCtD
Cevimeline—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.00024	CcSEcCtD
Cevimeline—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000239	CcSEcCtD
Cevimeline—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000217	0.000239	CcSEcCtD
Cevimeline—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000217	0.000239	CcSEcCtD
Cevimeline—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000239	CcSEcCtD
Cevimeline—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000239	CcSEcCtD
Cevimeline—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000217	0.000239	CcSEcCtD
Cevimeline—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000237	CcSEcCtD
Cevimeline—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000216	0.000237	CcSEcCtD
Cevimeline—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000215	0.000237	CcSEcCtD
Cevimeline—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000237	CcSEcCtD
Cevimeline—Rash—Vincristine—peripheral nervous system neoplasm	0.000214	0.000235	CcSEcCtD
Cevimeline—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000214	0.000235	CcSEcCtD
Cevimeline—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000235	CcSEcCtD
Cevimeline—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000235	CcSEcCtD
Cevimeline—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000234	CcSEcCtD
Cevimeline—Headache—Vincristine—peripheral nervous system neoplasm	0.000213	0.000234	CcSEcCtD
Cevimeline—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000232	CcSEcCtD
Cevimeline—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000231	CcSEcCtD
Cevimeline—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000209	0.00023	CcSEcCtD
Cevimeline—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000209	0.00023	CcSEcCtD
Cevimeline—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.00023	CcSEcCtD
Cevimeline—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000205	0.000226	CcSEcCtD
Cevimeline—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000223	CcSEcCtD
Cevimeline—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000203	0.000223	CcSEcCtD
Cevimeline—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000223	CcSEcCtD
Cevimeline—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000222	CcSEcCtD
Cevimeline—Nausea—Vincristine—peripheral nervous system neoplasm	0.000202	0.000222	CcSEcCtD
Cevimeline—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000221	CcSEcCtD
Cevimeline—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000221	CcSEcCtD
Cevimeline—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000221	CcSEcCtD
Cevimeline—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000221	CcSEcCtD
Cevimeline—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.00022	CcSEcCtD
Cevimeline—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000219	CcSEcCtD
Cevimeline—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000218	CcSEcCtD
Cevimeline—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000197	0.000217	CcSEcCtD
Cevimeline—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000217	CcSEcCtD
Cevimeline—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000216	CcSEcCtD
Cevimeline—Chills—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000214	CcSEcCtD
Cevimeline—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000195	0.000214	CcSEcCtD
Cevimeline—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000213	CcSEcCtD
Cevimeline—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000213	CcSEcCtD
Cevimeline—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000211	CcSEcCtD
Cevimeline—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000191	0.00021	CcSEcCtD
Cevimeline—Rash—Cisplatin—peripheral nervous system neoplasm	0.000189	0.000208	CcSEcCtD
Cevimeline—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000189	0.000208	CcSEcCtD
Cevimeline—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000208	CcSEcCtD
Cevimeline—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000188	0.000207	CcSEcCtD
Cevimeline—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000206	CcSEcCtD
Cevimeline—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000206	CcSEcCtD
Cevimeline—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000205	CcSEcCtD
Cevimeline—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000205	CcSEcCtD
Cevimeline—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000205	CcSEcCtD
Cevimeline—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000203	CcSEcCtD
Cevimeline—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000201	CcSEcCtD
Cevimeline—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.0002	CcSEcCtD
Cevimeline—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000182	0.0002	CcSEcCtD
Cevimeline—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000182	0.0002	CcSEcCtD
Cevimeline—Chills—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000198	CcSEcCtD
Cevimeline—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000197	CcSEcCtD
Cevimeline—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000178	0.000196	CcSEcCtD
Cevimeline—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000195	CcSEcCtD
Cevimeline—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000193	CcSEcCtD
Cevimeline—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000175	0.000192	CcSEcCtD
Cevimeline—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000192	CcSEcCtD
Cevimeline—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000192	CcSEcCtD
Cevimeline—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000191	CcSEcCtD
Cevimeline—Rash—Etoposide—peripheral nervous system neoplasm	0.000173	0.000191	CcSEcCtD
Cevimeline—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000173	0.000191	CcSEcCtD
Cevimeline—Headache—Etoposide—peripheral nervous system neoplasm	0.000172	0.000189	CcSEcCtD
Cevimeline—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000189	CcSEcCtD
Cevimeline—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000188	CcSEcCtD
Cevimeline—Malaise—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000187	CcSEcCtD
Cevimeline—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000187	CcSEcCtD
Cevimeline—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000186	CcSEcCtD
Cevimeline—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000186	CcSEcCtD
Cevimeline—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000186	CcSEcCtD
Cevimeline—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000185	CcSEcCtD
Cevimeline—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000184	CcSEcCtD
Cevimeline—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000183	CcSEcCtD
Cevimeline—Cough—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000181	CcSEcCtD
Cevimeline—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000164	0.00018	CcSEcCtD
Cevimeline—Nausea—Etoposide—peripheral nervous system neoplasm	0.000163	0.00018	CcSEcCtD
Cevimeline—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000179	CcSEcCtD
Cevimeline—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000178	CcSEcCtD
Cevimeline—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000178	CcSEcCtD
Cevimeline—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000177	CcSEcCtD
Cevimeline—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000177	CcSEcCtD
Cevimeline—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000177	CcSEcCtD
Cevimeline—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000177	CcSEcCtD
Cevimeline—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000176	CcSEcCtD
Cevimeline—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000175	CcSEcCtD
Cevimeline—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000173	CcSEcCtD
Cevimeline—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000173	CcSEcCtD
Cevimeline—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000172	CcSEcCtD
Cevimeline—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000172	CcSEcCtD
Cevimeline—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000171	CcSEcCtD
Cevimeline—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.00017	CcSEcCtD
Cevimeline—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000154	0.00017	CcSEcCtD
Cevimeline—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000169	CcSEcCtD
Cevimeline—Infection—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000168	CcSEcCtD
Cevimeline—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000168	CcSEcCtD
Cevimeline—Shock—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000167	CcSEcCtD
Cevimeline—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000167	CcSEcCtD
Cevimeline—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000166	CcSEcCtD
Cevimeline—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000166	CcSEcCtD
Cevimeline—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000166	CcSEcCtD
Cevimeline—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000165	CcSEcCtD
Cevimeline—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000165	CcSEcCtD
Cevimeline—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000164	CcSEcCtD
Cevimeline—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000164	CcSEcCtD
Cevimeline—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000164	CcSEcCtD
Cevimeline—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000164	CcSEcCtD
Cevimeline—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000163	CcSEcCtD
Cevimeline—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000162	CcSEcCtD
Cevimeline—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000162	CcSEcCtD
Cevimeline—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000158	CcSEcCtD
Cevimeline—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000158	CcSEcCtD
Cevimeline—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000157	CcSEcCtD
Cevimeline—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000156	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000154	CcSEcCtD
Cevimeline—Shock—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000154	CcSEcCtD
Cevimeline—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000154	CcSEcCtD
Cevimeline—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000154	CcSEcCtD
Cevimeline—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000153	CcSEcCtD
Cevimeline—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000153	CcSEcCtD
Cevimeline—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000152	CcSEcCtD
Cevimeline—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000152	CcSEcCtD
Cevimeline—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000152	CcSEcCtD
Cevimeline—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000151	CcSEcCtD
Cevimeline—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000151	CcSEcCtD
Cevimeline—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.00015	CcSEcCtD
Cevimeline—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000149	CcSEcCtD
Cevimeline—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000147	CcSEcCtD
Cevimeline—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000147	CcSEcCtD
Cevimeline—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000146	CcSEcCtD
Cevimeline—Pain—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000145	CcSEcCtD
Cevimeline—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000145	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000143	CcSEcCtD
Cevimeline—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000142	CcSEcCtD
Cevimeline—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000141	CcSEcCtD
Cevimeline—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.00014	CcSEcCtD
Cevimeline—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000127	0.00014	CcSEcCtD
Cevimeline—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000139	CcSEcCtD
Cevimeline—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000139	CcSEcCtD
Cevimeline—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000138	CcSEcCtD
Cevimeline—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000136	CcSEcCtD
Cevimeline—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000135	CcSEcCtD
Cevimeline—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000135	CcSEcCtD
Cevimeline—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000134	CcSEcCtD
Cevimeline—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000134	CcSEcCtD
Cevimeline—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000134	CcSEcCtD
Cevimeline—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000134	CcSEcCtD
Cevimeline—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000129	CcSEcCtD
Cevimeline—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000128	CcSEcCtD
Cevimeline—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000125	CcSEcCtD
Cevimeline—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000125	CcSEcCtD
Cevimeline—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000124	CcSEcCtD
Cevimeline—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000124	CcSEcCtD
Cevimeline—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000122	CcSEcCtD
Cevimeline—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000109	0.00012	CcSEcCtD
Cevimeline—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000116	CcSEcCtD
Cevimeline—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000116	CcSEcCtD
Cevimeline—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000113	CcSEcCtD
Cevimeline—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000112	CcSEcCtD
Cevimeline—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000111	CcSEcCtD
Cevimeline—Vomiting—Epirubicin—peripheral nervous system neoplasm	9.8e-05	0.000108	CcSEcCtD
Cevimeline—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	9.76e-05	0.000107	CcSEcCtD
Cevimeline—Rash—Epirubicin—peripheral nervous system neoplasm	9.72e-05	0.000107	CcSEcCtD
Cevimeline—Dermatitis—Epirubicin—peripheral nervous system neoplasm	9.71e-05	0.000107	CcSEcCtD
Cevimeline—Headache—Epirubicin—peripheral nervous system neoplasm	9.66e-05	0.000106	CcSEcCtD
Cevimeline—Dizziness—Doxorubicin—peripheral nervous system neoplasm	9.43e-05	0.000104	CcSEcCtD
Cevimeline—Nausea—Epirubicin—peripheral nervous system neoplasm	9.16e-05	0.000101	CcSEcCtD
Cevimeline—Vomiting—Doxorubicin—peripheral nervous system neoplasm	9.07e-05	9.97e-05	CcSEcCtD
Cevimeline—Rash—Doxorubicin—peripheral nervous system neoplasm	8.99e-05	9.89e-05	CcSEcCtD
Cevimeline—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	8.98e-05	9.88e-05	CcSEcCtD
Cevimeline—Headache—Doxorubicin—peripheral nervous system neoplasm	8.94e-05	9.83e-05	CcSEcCtD
Cevimeline—Nausea—Doxorubicin—peripheral nervous system neoplasm	8.47e-05	9.32e-05	CcSEcCtD
